Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -700 | N/A | 118,900 | 109,700 | 78,800 |
| Depreciation Amortization | 18,300 | N/A | 39,300 | 26,300 | 13,200 |
| Income taxes - deferred | 2,700 | N/A | -24,900 | -25,900 | 4,700 |
| Accounts receivable | -3,300 | N/A | -14,400 | -13,000 | -6,200 |
| Accounts payable and accrued liabilities | -8,400 | N/A | -2,000 | 3,000 | 400 |
| Other Working Capital | -14,900 | N/A | -6,100 | -15,100 | -13,100 |
| Other Operating Activity | 14,100 | 0 | -42,800 | -28,500 | -54,300 |
| Operating Cash Flow | $7,800 | $N/A | $68,000 | $56,500 | $23,500 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,300 | N/A | -6,600 | -3,700 | -1,600 |
| Net Acquisitions | -279,600 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -14,400 | N/A | -79,400 | -61,300 | -31,500 |
| Sale Of Investment | 16,300 | N/A | 65,500 | 45,200 | 17,900 |
| Investing Cash Flow | $-279,000 | $N/A | $-20,500 | $-19,800 | $-15,200 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 290,000 | N/A | 53,000 | N/A | 0 |
| Debt Repayment | -40,000 | N/A | -83,000 | -56,000 | -25,000 |
| Common Stock Issued | 2,100 | N/A | 18,200 | 6,300 | 1,700 |
| Other Financing Activity | 0 | 0 | -41,900 | 300 | 0 |
| Financing Cash Flow | $252,100 | $N/A | $-53,700 | $-49,400 | $-23,300 |
| Exchange Rate Effect | 1,500 | N/A | 1,200 | -1,000 | 500 |
| Beginning Cash Position | 110,900 | N/A | 102,400 | 102,400 | 102,400 |
| End Cash Position | 93,300 | N/A | 97,400 | 88,700 | 87,900 |
| Net Cash Flow | $-17,600 | $N/A | $-5,000 | $-13,700 | $-14,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,800 | N/A | 68,000 | 56,500 | 23,500 |
| Capital Expenditure | -1,300 | N/A | -6,600 | -3,700 | -1,600 |
| Free Cash Flow | 6,500 | 0 | 61,400 | 52,800 | 21,900 |